Show simple item record

dc.contributor.authorRanson, Malcolm R
dc.contributor.authorThatcher, Nick
dc.date.accessioned2009-08-21T14:17:44Z
dc.date.available2009-08-21T14:17:44Z
dc.date.issued2003-04
dc.identifier.citationCommentary on ZD1839 (Iressa) in non small cell lung cancer. 2003, 40 (1):77-8 Lung Canceren
dc.identifier.issn0169-5002
dc.identifier.pmid12660010
dc.identifier.urihttp://hdl.handle.net/10541/78220
dc.language.isoenen
dc.subjectLung Canceren
dc.subject.meshAntineoplastic Agents
dc.subject.meshCarcinoma, Non-Small-Cell Lung
dc.subject.meshClinical Trials as Topic
dc.subject.meshHumans
dc.subject.meshLung Neoplasms
dc.subject.meshProtein-Tyrosine Kinases
dc.subject.meshQuinazolines
dc.titleCommentary on ZD1839 (Iressa) in non small cell lung cancer.en
dc.typeArticleen
dc.contributor.departmentCR-UK Department of Medical Oncology, Christie Hospital NHS Trust, University of Manchester, Wilmslow Road, Manchester, M20 4BX, UK. malcolm.ranson@man.ac.uken
dc.identifier.journalLung Canceren


This item appears in the following Collection(s)

Show simple item record